TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05098535

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visual Aid
Description: The visual aid will include a graphic display of 100 individuals with number of individuals anticipated to suffer a myocardial injury highlighted by being filled in in red. There will also be a textual description stating the anticipated risk.~For example in a patient with an rCRI score = 2 the text will state 10 out of 100 patients will have a myocardial injury (MINS) and 90 out of 100 patients will have no myocardial injury and 10 of the patients will be shaded red on the visual aid. The patients in this intervention will also received the scripted discussion of perioperative risk of MINS.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Scripted Risk Discussion
Description: The patients seen in PSS will have a standardized discussion of perioperative risk of myocardial injury read to them by the anesthesiologist in the PSS clinic.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scripted Risk Discussion
Description: The patients seen in PSS will have a standardized discussion of perioperative risk of myocardial injury read to them by the anesthesiologist in the PSS clinic.
Study: NCT06428734

Intervention type: DIAGNOSTIC_TEST
Intervention: hydrocephalus group
Description: Diagnostic Test: high throughput sequencing and electromyography Whole Genome Sequencing, Whole Exome Sequencing, Transcriptomics, Proteomics, Metabolomics and imaging, such as DTIALPS

Intervention type: OTHER
Intervention: normal group
Description: Whole Genome Sequencing, Whole Exome Sequencing, Transcriptomics, Proteomics, Metabolomics and imaging, such as DTIALPS
Study: NCT04742439

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham transcranial direct current stimulation
Description: Participants will receive 30 seconds of ramp up and down stimulation at the start and end of the 20 minute stimulation period.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Individualized transcranial direct current stimulation
Description: Participants will receive 20 minutes of transcranial direct current stimulation (tDCS) at the individualized dose (maximum of 4mA).

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 2mA transcranial direct current stimulation
Description: Participants will receive 20 minutes of transcranial direct current stimulation (tDCS) at a 2mA dose.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 4mA transcranial direct current stimulation
Description: Participants will receive 20 minutes of transcranial direct current stimulation (tDCS) at a 4mA dose.
Study: NCT06327048

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individual cognitive rehabilitation training based on Remind strategy was given
Description: This training educates and learns patients from the aspects of assessment of cognitive function and strategic compensation for the impact of cognitive impairment on patients, and then conducts attention, memory and executive function training and attention retraining based on patients' cognitive function to improve patients' cognitive function
Study: NCT06282263

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Awareness Development Program on Suicide Prevention for Oncology Nurses
Description: While developing the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to the nurses in the experimental group, literature information on suicide risk management and suicide prevention in oncology was included in the study content by the researchers. Awareness Development Programme on Suicide Prevention for Oncology Nurses includes 3 sessions and the titles of the programme are as follows:~Session 1: Introduction to Understanding Suicide Awareness and Development Session 2: Assessing Suicide Risk Session 3: Management of Suicide Risk Communication and Referral The programme was submitted to the opinions of 5 experts before starting the study and the programme was finalised after the feedbacks.
Study: NCT05681221

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nano silver particles and calcium hydroxide
Description: Combination of two materials that can possibly eradicate the mixed odontogenic infection in the periapical area and dentinal tubules in necrotic primary second molars.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: TAP
Description: Triple antibiotic paste (TAP) is considered the gold standard in LSTR. It is a combination of ciprofloxacin, metronidazole and minocycline. Many anaerobic bacteria are resistant to ciprofloxacin. Hence, it is often used with metronidazole in treating mixed infections to compensate for its limited scope. Therefore, TAP can affect gram-negative, gram-positive, and anaerobic bacteria, and this combination can be effective against odontogenic microorganisms.
Study: NCT05070494

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Egg-derived standard dose trivalent influenza vaccine (surface antigen, inactivated)
Description: study of immunologic response to different dose and duration of Egg-derived standard dose trivalent influenza vaccine (surface antigen, inactivated)

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Egg-derived standard dose trivalent influenza vaccine (surface antigen, inactivated)
Description: study of immunologic response to different dose and duration of Egg-derived standard dose trivalent influenza vaccine (surface antigen, inactivated)

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Egg-derived standard dose trivalent influenza vaccine (surface antigen, inactivated)
Description: study of immunologic response to different dose and duration of Egg-derived standard dose trivalent influenza vaccine (surface antigen, inactivated)

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Egg-derived standard dose trivalent influenza vaccine (surface antigen, inactivated)
Description: study of immunologic response to different dose and duration of Egg-derived standard dose trivalent influenza vaccine (surface antigen, inactivated)
Study: NCT04959682

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Intervention
Description: After rating levels of fatigue and relaxation, the professional health care musicians will play 30 minutes of patient-tailored, pleasant instrumental music with a combination of relaxing (on average 60-80 bpm) and lively, slightly more up-beat tempo to regulate arousal-levels
Study: NCT05784168

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual therapy
Description: 6 weeks, 12 sessions in total, 2 times a week of manual therapy: spinal manipulation, specific mobilisations and stretches. Manual therapy treatments are carried out by a physiotherapist with more than 10 years of experience.~In addition, 6 weeks, 5 times a week, a programme of therapeutic exercises at home: muscle strengthening and stretching, balance and coordination training, spinal stabilisation exercises.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise therapy
Description: 6 weeks, 12 sessions in total, 2 times a week therapeutic exercise programme under the supervision of a physiotherapist. The exercise programme consisted of muscle strengthening and stretching, balance and coordination training, spinal stabilisation exercises.~In addition, 6 weeks, 5 times a week, a programme of therapeutic exercises at home: muscle strengthening and stretching, balance and coordination training, spinal stabilisation exercises.
Study: NCT05499104

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NovaDress
Description: NovaDress is constructed of pure cellulose derived from tree pulp. The tree pulp is reconstructed into hydrated sheets wrapped in nonwoven viscose and irradiated.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Mepilex Ag
Description: Mepilex Ag is an antimicrobial foam dressing that absorbs low to moderate exudate and maintains a moist wound environment.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Xeroform
Description: Xeroform® Occlusive Dressing (XF) is a fine-mesh gauze impregnated with a petrolatum blend, 3% bismuth tribromophenate.
Study: NCT05100693

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fetoscopic Endoluminal Tracheal Occlusion with the Smart-TO Balloon
Description: Fetal Endoscopic Tracheal Occlusion using the Smart-TO balloon and non-invasive balloon removal by the peripheral magnetic field of an magnetic resonance scanner.
Study: NCT05181501

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fully human BCMA chimeric antigen receptor autologous T cell injection (CT103A)
Description: CT103A is a customized, BCMA-targeted genetically modified autologous T cell immunotherapy, which can identify and eliminate malignant and normal cells expressing BCMA. CAR specifically recognizes BCMA with single chain fragment variable (ScFv), and promotes the activation, proliferation, cytokine secretion and target cell killing of CAR-T through the CD3ζ domain. And 4-1BB enhances the expansion and persistence of CT103A.~CT103A will be infused at 1.0×10\^6 /kg via intravenous drip within 24h to 72h after chemotherapy conditioning regimen at the recommended infusion rate of 3-5 mL/min.
Study: NCT06567444

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Working memory intervention
Description: During the intervention, the participants in the ADHD group received five computerized working memory training sessions per week over five weeks, and each session lasted 20 minutes. This training paradigm is based on previous studies which show improvements in working memory capacities after a 5-week training period.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Working memory intervention
Description: During the intervention, the participants in the ADHD group received five computerized working memory training sessions per week over five weeks, and each session lasted 20 minutes. This training paradigm is based on previous studies which show improvements in working memory capacities after a 5-week training period.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Working memory intervention
Description: During the intervention, the participants in the ADHD group received five computerized working memory training sessions per week over five weeks, and each session lasted 20 minutes. This training paradigm is based on previous studies which show improvements in working memory capacities after a 5-week training period.
Study: NCT06538389

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BRC-001
Description: Given PO
Study: NCT02990793

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active MeRT Treatment
Description: A personalized biometrics-guided protocol known as magnetic EEG/ECG resonance therapy (MeRT) treatment that is tailored specifically to each participant's EEG intrinsic alpha frequency (IAF). rTMS is applied at the participant's IAF.
Study: NCT06538389

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Administration
Description: Given PO

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study: NCT05293119

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JAK-2 inhibitor
Description: In this trial, one group will receive the tofacitinib 5 mg twice daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topical corticosteroid
Description: Mometasone furoate 0.1% ointment once daily
Study: NCT06196437

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Participants will receive acupuncture.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Acupuncture
Description: Participants will receive sham acupuncture.
Study: NCT06476353

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Analysis of Force and Pressure Requirements across Syringe Sizes for Pain Management Procedures
Description: The investigators are analyzing the compression force required to plunge different syringe sizes to determine the operator's burden.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Analysis of Force and Pressure Requirements across Syringe Sizes for Pain Management Procedures
Description: The investigators are analyzing the compression force required to plunge different syringe sizes to determine the operator's burden.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Analysis of Force and Pressure Requirements across Syringe Sizes for Pain Management Procedures
Description: The investigators are analyzing the compression force required to plunge different syringe sizes to determine the operator's burden.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Analysis of Force and Pressure Requirements across Syringe Sizes for Pain Management Procedures
Description: The investigators are analyzing the compression force required to plunge different syringe sizes to determine the operator's burden.
Study: NCT05696756

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Personalized Web-based training for EMMA app
Description: Participants will complete six sessions of training to support uptake and habit formation of EMMA app use with a personalized web-based training platform.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Personalized Web-based training for EMMA app
Description: Participants will complete six sessions of training to support uptake and habit formation of EMMA app use with a personalized web-based training platform.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing: Clinician Support
Description: Participants will receive weekly brief check-ins with clinicians to motivate and support the problem-solving and habit formation aspects of the web-based training.
Study: NCT06148883

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transcatheter Aortic Valve Implantation
Description: Transcatheter Aortic Valve Implantation is the implantation of a biological aortic valve percutaneously

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transcatheter Aortic Valve Implantation
Description: Transcatheter Aortic Valve Implantation is the implantation of a biological aortic valve percutaneously
Study: NCT02990793

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham MeRT Treatment
Description: rTMS coil does not emit magnetic stimulation.
Study: NCT06538389

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study: NCT06405750

Intervention type: PROCEDURE
Group type: OTHER
Intervention: left atrial appendage closure
Description: systematic closure of the left atrial appendage in addition to the planned heart surgery
Study: NCT05471154

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High Definition transcranial direct current stimulation (HD-tDCS)
Description: HD-tDCS is used at 2mA and during 20 minutes and with electrodes positioned on regions F4 (anode), Fp2, Fz, F8 and C4 (cathodes), according to the international 10-20 electroencephalogram system. 5 sessions are given on 5 following days. The material used in this study is the Soterix Medical 1x1 tES mini-CT and HD 4x1 splitter, produced by Soterix Medical Inc., 237 W 35th St, New York, NY 10001, United States of America.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: High Definition transcranial direct current stimulation (HD-tDCS)
Description: HD-tDCS is used at 2mA and during 20 minutes and with electrodes positioned on regions F4 (anode), Fp2, Fz, F8 and C4 (cathodes), according to the international 10-20 electroencephalogram system. 5 sessions are given on 5 following days. The material used in this study is the Soterix Medical 1x1 tES mini-CT and HD 4x1 splitter, produced by Soterix Medical Inc., 237 W 35th St, New York, NY 10001, United States of America.
Study: NCT04290871

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitric Oxide Gas
Description: Inspired NO/N2 will be delivered at 80 parts per million (ppm) in the first 48 hours of enrollment (within 48 hours after initiation of mechanical ventilation). Weaning from NO will start after 48-h consecutive NO inhalation. The physicians will follow their own institutional weaning protocols.
Study: NCT06108817

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Information material
Description: The intervention consists of the distribution of a poster for the waiting room and flyers to be given to patients aiming to inform both patients and GPs with respect to the correct indications for treatment of dyspepsia. After signing up, practices assigned to the intervention group received a package containing 60 flyers and one waiting room poster to use during consultations. The flyer and poster provide a short description of the correct indications for treatment of dyspepsia. Additionally, both the flyers and posters contained a QR-code linking to a decision aid explaining the correct indications and causes of dyspepsia.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No Intervention
Description: These practices do not receive information material
Study: NCT04290871

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: The delivery system will be set up anyway without study gas administration
Description: The delivery system will be set up anyway without study gas administration
Study: NCT03033472

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 600 mg Clindamycin orally
Description: 600 mg Clindamycin orally 30 minutes before treatment

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oral Placebo
Description: Oral Placebo 30 minutes before treatment
Study: NCT06180655

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diabetes Self-Management Education and Support (DSMES) plus Tai Chi Easy (TCE)™
Description: Participants will be asked to attend 45 minutes of DSMES and 45 min of TCE twice a week for 6 weeks. All classes will be recorded and available online and can viewed at a time when it is most convenient to accommodate working adults.
Study: NCT04997200

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: One night's sleeplessness
Description: A night without sleep. No daytime sleeping the day before the test. Participants are observed by staff at the trial unit during the night before the test.
Study: NCT04718363

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PNF stretching
Description: A contract-relax PNF stretching technique will be applied to hamstring muscle.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-vibration foam rolling prior to PNF stretching
Description: Prior to PNF stretching, participant will perform unilateral hamstring non-vibration foam rolling.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vibration foam rolling prior to PNF stretching
Description: Prior to PNF stretching, participant will perform unilateral hamstring vibration foam rolling (48 Hz).
Study: NCT05579509

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam and Fentanyl
Description: Prior to the start of the nerve block, patients in Arm 1 will receive titrated pharmacological sedation with IV midazolam with a goal of achieving moderate sedation. If pain is felt despite subcutaneous lidocaine, IV fentanyl may be administered with a goal of achieving moderate sedation with analgesia.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam and Fentanyl
Description: Prior to the start of the nerve block, patients in Arm 1 will receive titrated pharmacological sedation with IV midazolam with a goal of achieving moderate sedation. If pain is felt despite subcutaneous lidocaine, IV fentanyl may be administered with a goal of achieving moderate sedation with analgesia.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational Reassurance
Description: Patients in the nonpharmacologic group will receive intraprocedural education and reassurance without pharmacologic sedation. They will have the option to receive more pharmacologic sedation at any point during the nerve block (cross-over to titrated sedation group).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational Reassurance
Description: Patients in the nonpharmacologic group will receive intraprocedural education and reassurance without pharmacologic sedation. They will have the option to receive more pharmacologic sedation at any point during the nerve block (cross-over to titrated sedation group).
Study: NCT04746495

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will go through a 2-week wash-in period. During the wash-in period, the participant will be asked not to take their usual antihypertensive medications for their mild hypertension. After the 2-week wash-in period, the participants will begin a 4-week treatment period and will take a placebo once a day for 4 weeks. After the 4 weeks, the participants will have a 2-week wash-out period where they will be off the study treatment. After the 2-week wash-out period, the participants will begin the Eplerenone treatment for another 4 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eplerenone 50mg
Description: Participants will go through a 2-week wash-in period. During the wash-in period, the participant will be asked not to take their usual antihypertensive medications for their mild hypertension. After the 2-week wash-in period, the participants will begin a 4-week treatment period of Eplerenone for 4 weeks. After the 4 weeks, the participants will have a 2-week wash-out period where they will be off the study treatment. After the 2-week wash-out period, the participants will then begin the Placebo treatment for another 4 weeks.